Literature DB >> 24639268

PDA ligation and health outcomes: a meta-analysis.

Dany E Weisz1, Kiran More, Patrick J McNamara, Prakesh S Shah.   

Abstract

BACKGROUND AND
OBJECTIVE: Patent ductus arteriosus (PDA) ligation has been variably associated with neonatal morbidities and neurodevelopmental impairment (NDI). The objective was to systematically review and meta-analyze the impact of PDA ligation in preterm infants at <32 weeks' gestation on the risk of mortality, severe neonatal morbidities, and NDI in early childhood.
METHODS: Medline, Embase, Cochrane Central Register of Controlled Trials, Education Resources Information Centre (ERIC), Cumulative Index to Nursing and Allied Health (CINAHL), PsycINFO, and the Dissertation database were searched (1947 through August 2013). Risk of bias was assessed by using the Newcastle-Ottawa Scale and the Cochrane Risk of Bias tool. Meta-analyses were performed by using a random-effects model. Unadjusted and adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were pooled when appropriate.
RESULTS: Thirty-nine cohort studies and 1 randomized controlled trial were included. Nearly all cohort studies had at least moderate risk of bias mainly due to failure to adjust for survival bias and important postnatal preligation confounders such as ventilator dependence, intraventricular hemorrhage, and sepsis. Compared with medical treatment, surgical ligation was associated with increases in NDI (aOR: 1.54; 95% CI: 1.01-2.33), chronic lung disease (aOR: 2.51; 95% CI: 1.98-3.18), and severe retinopathy of prematurity (aOR: 2.23; 95% CI: 1.62-3.08) but with a reduction in mortality (aOR: 0.54; 95% CI: 0.38-0.77). There was no difference in the composite outcome of death or NDI in early childhood (aOR: 0.95; 95% CI: 0.58-1.57).
CONCLUSIONS: Surgical ligation of PDA is associated with reduced mortality, but surviving infants are at increased risk of NDI. However, there is a lack of studies addressing survival bias and confounding by indication.

Entities:  

Keywords:  cerebral palsy; chronic lung disease; cognitive impairment; death; mortality; neurodevelopmental impairment; patent ductus arteriosus; retinopathy of prematurity

Mesh:

Year:  2014        PMID: 24639268     DOI: 10.1542/peds.2013-3431

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

2.  Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.

Authors:  Dany E Weisz; Lucia Mirea; Erin Rosenberg; Maximus Jang; Linh Ly; Paige T Church; Edmond Kelly; S Joseph Kim; Amish Jain; Patrick J McNamara; Prakesh S Shah
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

3.  Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus.

Authors:  D E Weisz; F F Martins; L E Nield; A El-Khuffash; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

4.  Acetaminophen for Patent Ductus Arteriosus in Extremely Low-Birth-Weight Neonates.

Authors:  Caitlyn M Luecke; Caren J Liviskie; Brandy N Zeller; Zachary A Vesoulis; Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

5.  A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants.

Authors:  J M Davidson; J Ferguson; E Ivey; R Philip; M F Weems; A J Talati
Journal:  J Perinatol       Date:  2020-05-21       Impact factor: 2.521

6.  Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Sophia M Ansems; Haresh Kirpalani; Laura Mercer-Rosa; Yan Wang; Rachel K Hopper; María V Fraga; Erik A Jensen
Journal:  Neonatology       Date:  2019-07-03       Impact factor: 4.035

7.  Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.

Authors:  Samantha Ngo; Jochen Profit; Jeffrey B Gould; Henry C Lee
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 8.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

Review 9.  Patent Ductus Arteriosus of the Preterm Infant.

Authors:  Shannon E G Hamrick; Hannes Sallmon; Allison T Rose; Diego Porras; Elaine L Shelton; Jeff Reese; Georg Hansmann
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

10.  The impact of a dedicated patent ductus arteriosus ligation team on neonatal health-care outcomes.

Authors:  M H F Resende; K More; D Nicholls; J Ting; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.